psilocybin

Fluorinated Psilocin Derivative Cuts Psychedelic Effects 75% While Preserving Antidepressant Activity

by

TL;DR: Chemists designed a new psilocin derivative with fluorine modifications that induces sub-hallucinogenic effects in mice, sidestepping the acute psychological effects of classic psychedelics while retaining therapeutic serotonin receptor activity. Psilocybin has emerged as a clinical darling—mounting evidence shows rapid relief for depression, anxiety, and cluster headaches. But there’s a catch: the intense hallucinations and …

Read more

Revolutionizing Depression Treatment: Novel Rapid-Acting Antidepressants & Emerging Drug Targets

by

Major depressive disorder (MDD) is a global health crisis affecting over 300 million people. While available antidepressants help some patients, treatment is far from satisfactory for many. Exciting research into rapid-acting agents like ketamine and psilocybin combined with exploration of novel drug targets finally offers real hope for transformational change in how depression is treated. …

Read more

Psychedelics Linked to Nonconformist Beliefs & Alternative Facts

by

Classical psychedelics like LSD and psilocybin have recently re-entered mainstream discussions surrounding mental health. Small clinical trials have shown promising results for their therapeutic potential in treating conditions like depression, anxiety and addiction. However, beyond their clinical utility, many questions remain regarding the impact of these substances on psychological aspects like personality and belief systems. …

Read more

Psilocybin’s Rapid Anti-Inflammatory Effects (TNF-Alpha, IL-6, CRP) for Depression & Social Benefits

by

A new study provides evidence that the psychedelic compound psilocybin has both immediate and lasting anti-inflammatory effects in healthy volunteers. The findings shed light on how psilocybin may improve mood, social behavior, and potentially treat depression. Key facts: Psilocybin decreased the inflammatory marker TNF-alpha immediately after administration. Seven days later, psilocybin reduced two other inflammatory …

Read more

Psychedelics Flatten Brain’s ‘Energy Landscape’ & Increase Neural Diversity, New Study Finds

by

Researchers have discovered that classic psychedelic drugs like LSD and psilocybin (‘magic mushrooms’) flatten the energy landscape of the brain. This effect makes it easier for the brain to transition between different states of activity and leads to more diverse and entropic neural dynamics overall. Key Facts: Using fMRI data and network modeling, researchers found …

Read more